Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed · Phase 2

Conditions studied: COPD

In brief

The trial is designed to identify an appropriate dose of QAB149 for delivery via a multiple dose inhaler for use in the COPD Phase III program.

Key facts

Study ID
NCT00098228
Run by
Novartis Pharmaceuticals
People needed
686
Starts
2004-07-01
Expected to finish
2004-12-01
Last updated by the study team
2011-10-25

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.